| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-33699-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26618-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-55301-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-45051 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-22374-50ul | |||
![Immunocytochemistry/Immunofluorescence: HOXC10 Antibody [NBP2-33699] - Immunofluorescent staining of human cell line HeLa shows localization to nuclear bodies.](http://images.novusbio.com/fullsize/HOXC10-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-33699-img0005.jpg "Immunocytochemistry/Immunofluorescence: HOXC10 Antibody [NBP2-33699] - Immunofluorescent staining of human cell line HeLa shows localization to nuclear bodies.")
![Immunohistochemistry: HOXC10 Antibody [NBP2-33699] - Staining of human vulva/anal skin moderate nuclear positivity in epidermal cells.](http://images.novusbio.com/fullsize/HOXC10-Antibody-Immunohistochemistry-NBP2-33699-img0001.jpg)
![Western Blot: HOXC10 Antibody [NBP1-71932] - Whole cell lysate from HeLa (1 mg for IP, 20% of IP loaded) cells. Affinity purified rabbit anti-HOXC10 antibody used for IP at 6 mcg/mg lysate. HOXC10 was also immunoprecipitated by rabbit anti-HOXC10 antibody NBP1-71933, which recognizes a downstream epitope.](http://images.novusbio.com/fullsize/HOXC10-Antibody-Western-Blot-NBP1-71932-img0002.jpg "<b>Independent Antibodies Validation. </b>Western Blot: HOXC10 Antibody [NBP1-71932] - Whole cell lysate from HeLa (1 mg for IP, 20% of IP loaded) cells. Affinity purified rabbit anti-HOXC10 antibody used for IP at 6 mcg/mg lysate. HOXC10 was also immunoprecipitated by rabbit anti-HOXC10 antibody NBP1-71933, which recognizes a downstream epitope.")
![Immunocytochemistry/Immunofluorescence: HOXC10 Antibody (3F2) [H00003226-M01] - Analysis of monoclonal antibody to HOXC10 on HeLa cell . Antibody concentration 10 ug/ml.](http://images.novusbio.com/fullsize/HOXC10-Antibody-3F2-Immunocytochemistry-Immunofluorescence-H00003226-M01-img0003.jpg "Immunocytochemistry/Immunofluorescence: HOXC10 Antibody (3F2) [H00003226-M01] - Analysis of monoclonal antibody to HOXC10 on HeLa cell . Antibody concentration 10 ug/ml.")
![Sandwich ELISA: HOXC10 Antibody (3F2) [H00003226-M01] - Detection limit for recombinant GST tagged HOXC10 is approximately 0.03ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/HOXC10-Antibody-3F2-Sandwich-ELISA-H00003226-M01-img0004.jpg)
![SDS-Page: Recombinant Human NFIA Protein [H00004774-P01] - 12.5% SDS-PAGE Stained with Coomassie Blue.](http://images.novusbio.com/fullsize/qc_test-H00004774-P01-1.jpg "SDS-Page: Recombinant Human NFIA Protein [H00004774-P01] - 12.5% SDS-PAGE Stained with Coomassie Blue.")
![Immunocytochemistry/ Immunofluorescence: DLL3 Antibody (SC16.15) - Chimeric - BSA Free [NBP3-45128] - Immunofluorescence analysis of paraformaldehyde-fixed U2OS cells on coverslips stained with NBP3-45128 (1:100 dilution) for 1h followed by Alexa Fluor® 488 secondary antibody (1:1000 dilution), showing cytoplasmic, vesicle, and nuclear staining. The nuclear stain is DAPI (blue). Panels show, from left-right, top-bottom, NBP3-45128, DAPI, merged channels, and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor® 488 secondary antibody.](http://images.novusbio.com/fullsize/nbp3-45128_rabbit-dll3-mab-sc16-15-chimeric-bsa-free-immunocytochemistry-immunofluorescence-222026035558.png "Immunocytochemistry/ Immunofluorescence: DLL3 Antibody (SC16.15) - Chimeric - BSA Free [NBP3-45128] - Immunofluorescence analysis of paraformaldehyde-fixed U2OS cells on coverslips stained with NBP3-45128 (1:100 dilution) for 1h followed by Alexa Fluor® 488 secondary antibody (1:1000 dilution), showing cytoplasmic, vesicle, and nuclear staining. The nuclear stain is DAPI (blue). Panels show, from left-right, top-bottom, NBP3-45128, DAPI, merged channels, and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor® 488 secondary antibody.")
![Western Blot: HOXC10 Antibody [NBP1-71933] - Whole cell lysate from HeLa (15 and 50 mcg for WB; 1 mg for IP, 20% of IP loaded), Jurkat (J; 50 mcg) and 293T (T; 50 mcg) cells. Affinity purified rabbit anti-HOXC10 antibody used for WB at 0.1 mcg/ml (A) and 1 mcg/ml (B) and used for IP at 6 mcg/mg lysate. HOXC10 was also immunoprecipitated by rabbit anti-HOXC10 antibody NBP1-71932, which recognizes an upstream epitope.](http://images.novusbio.com/fullsize/HOXC10-Antibody-Western-Blot-NBP1-71933-img0003.jpg "<b>Independent Antibodies Validation and Biological Strategies Validation.</b>Western Blot: HOXC10 Antibody [NBP1-71933] - Whole cell lysate from HeLa (15 and 50 mcg for WB; 1 mg for IP, 20% of IP loaded), Jurkat (J; 50 mcg) and 293T (T; 50 mcg) cells. Affinity purified rabbit anti-HOXC10 antibody used for WB at 0.1 mcg/ml (A) and 1 mcg/ml (B) and used for IP at 6 mcg/mg lysate. HOXC10 was also immunoprecipitated by rabbit anti-HOXC10 antibody NBP1-71932, which recognizes an upstream epitope.")
![ELISA: DLL3 Antibody (7B7) [NBP3-26618] - The Binding Activity of DLL3 with DLL3 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized DLL3 at 2 ug/mL can bind DLL3 Antibody, the EC50 is 1.625-2.702 ng/mL.](http://images.novusbio.com/fullsize/nbp3-26618_human-dll3-mab-7b7-262202412272346.jpg "ELISA: DLL3 Antibody (7B7) [NBP3-26618] - The Binding Activity of DLL3 with DLL3 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized DLL3 at 2 ug/mL can bind DLL3 Antibody, the EC50 is 1.625-2.702 ng/mL.")
![ELISA: DLL3 Antibody (7B7) [NBP3-26618] - The Binding Activity of DLL3 with DLL3 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized DLL3 at 2 ug/mL can bind DLL3 Antibody, the EC50 is 1.102-1.707 ng/mL.](http://images.novusbio.com/fullsize/nbp3-26618_human-dll3-mab-7b7-262202412272316.jpg)
![Flow Cytometry: DLL3 Antibody (7B7) [NBP3-26618] - Untransfected HEK293 cells (green line) and transfected Human DLL3 HEK293 stable cells (red line) were stained with anti-DLL3 antibody (rovalpituzumab-like) (2ul/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG1 Fc antibody and analyzed with flow cytometry.](http://images.novusbio.com/fullsize/nbp3-26618_human-dll3-mab-7b7-282202414312733.jpg)
![Immunocytochemistry/Immunofluorescence: Jagged 2 Antibody [NBP2-55301] - Staining of human cell line A-431 shows localization to vesicles.](http://images.novusbio.com/fullsize/Jagged-2-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-55301-img0001.jpg "Immunocytochemistry/Immunofluorescence: Jagged 2 Antibody [NBP2-55301] - Staining of human cell line A-431 shows localization to vesicles.")
![Western Blot: Jagged 2 Antibody (SR1166) [NBP3-22374] - Western blot analysis using NBP3-22374 in HUVEC cell lysate.](http://images.novusbio.com/fullsize/nbp3-22374_rabbit-jagged-2-mab-sr1166-57202315521827.jpg "Western Blot: Jagged 2 Antibody (SR1166) [NBP3-22374] - Western blot analysis using NBP3-22374 in HUVEC cell lysate.")